A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma, demonstrate researchers at Tokyo Tech. The agent is selectively absorbed by brain tumor ...
Attendees celebrated the accomplishments of a 10-year collaboration leading to the first patients treated in 2025 -- The first clinical trial at the HUS BNCT facility is nearing completion HELSINKI ...
Boron Neutron Capture Therapy (BNCT) is a targeted radiotherapeutic modality that exploits the nuclear reaction between boron-10 and low-energy thermal neutrons. This reaction produces high-linear ...
NEW YORK--(BUSINESS WIRE)--Aviko Radiopharmaceuticals, a Deerfield Management-founded biotechnology company, is advancing precision boron neutron capture therapy (BNCT) to treat a variety of cancers ...
HSINCHU, Taiwan--(BUSINESS WIRE)--On February 14 th the melodious strains of the fourth movement of Mahler's Fifth Symphony were heard inside the building of Tsing Hua Open pool Reactor (THOR) at ...
Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: Implications for hippocampal sparing irradiation. This is an ASCO Meeting Abstract from the ...
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue. Researchers found ...
A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumours in some cancers. In a new article in the ...
Glioblastoma is an aggressive malignancy and accounts for about 15 per cent of all brain tumours. Even when initially controlled by treatment, the cancer almost always returns. Surgery and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results